LENZ Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.9M | 1.6M | 12.5M | 5.0M | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 1.2M | 525K | 125K | 19K | 36K | 0 | 0 | 0 |
| Gross Profit | 714K | 1.1M | 12.4M | 5.0M | -36K | 0 | 0 | 0 |
| R&D Expenses | 0 | 0 | 3.8M | 9.1M | 5.8M | 5.9M | 6.5M | 6.9M |
| Operating Expenses | 44.8M | 39.5M | 31.3M | 21.8M | 16.9M | 15.2M | 12.9M | 14.4M |
| Operating Income | -44.1M | -38.5M | -18.9M | -16.9M | -16.9M | -15.2M | -12.9M | -14.4M |
| Other Income / Gains | 2.6M | 2.6M | 2.2M | 2.4M | 2.3M | 2.6M | 2.7M | 4.1M |
| Net Income | -41.5M | -35.9M | -16.7M | -14.9M | -14.6M | -12.7M | -10.2M | -10.3M |
| EPS (Diluted) | -1.32 | -1.16 | -0.59 | -0.53 | -0.53 | -0.46 | -0.38 | -0.40 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.376 | 0.669 | 0.99 | 0.996 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 44.8M | 39.5M | 27.5M | 12.8M | 11.1M | 9.4M | 6.5M | 7.4M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 46.0M | 40.1M | 31.4M | 21.9M | 16.9M | 15.2M | 12.9M | 14.4M |
| Interest Income | 2.6M | 3.0M | 2.2M | 2.2M | 2.3M | 2.6M | 2.7M | 2.5M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 111K | 107K | 125K | 19K | 36K | 25K | 10K | 18K |
| Ebitda | -41.4M | -35.8M | -16.6M | -14.4M | -14.6M | -12.6M | -10.2M | -10.2M |
| Ebitdaratio | -21.766 | -22.536 | -1.326 | -2.879 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | -23.217 | -24.221 | -1.511 | -3.371 | 0 | 0 | 0 | 0 |
| Income Before Tax | -41.5M | -35.9M | -16.7M | -14.4M | -14.6M | -12.7M | -10.2M | -10.3M |
| Income Before Tax Ratio | -21.824 | -22.603 | -1.336 | -2.882 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 2K | 0 | 500K | 0 | 1K | 0 | 0 |
| Net Income Ratio | -21.824 | -22.605 | -1.336 | -2.982 | 0 | 0 | 0 | 0 |
| Epsdiluted | -1.32 | -1.16 | -0.59 | -0.53 | -0.53 | -0.46 | -0.38 | -0.40 |
| Weighted Average Shs Out | 31.4M | 31.1M | 28.5M | 28.1M | 27.5M | 27.5M | 27.2M | 25.6M |
| Weighted Average Shs Out Dil | 31.4M | 31.1M | 28.5M | 28.1M | 27.5M | 27.5M | 27.2M | 25.6M |